Current bioengineering methods for whole kidney regeneration

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Yamanaka, Shuichiro ^a   Yokoo, Takashi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOGENIC PROTEIN 1; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR PAX2;

ARTICLE; ARTIFICIAL KIDNEY; BIOENGINEERING; BLASTOCYST; CHRONIC KIDNEY DISEASE; COCULTURE; EMBRYONIC STEM CELL; END STAGE RENAL DISEASE; EPITHELIUM CELL; HIGH THROUGHPUT SCREENING; HUMAN; KIDNEY FUNCTION; KIDNEY REGENERATION; MEMBRANE RECONSTITUTION; MOLECULAR WEIGHT; NEPHRON; NONHUMAN; ORGAN TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REGENERATION;

EID: 84930652559     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/724047     Document Type: Article

References (94)

1. S. F. Badylak, D. Taylor, and K. Uygun, "Whole-organ tissue engineering: decellularization and recellularization of threedimensional matrix scaffolds," Annual Review of Biomedical Engineering, vol. 13, pp. 27-53, 2011.
2. Q. Al-Awqati and J. A. Oliver, "Stem cells in the kidney," Kidney International, vol. 61, no. 2, pp. 387-395, 2002.
3. F. Locatelli, U. Buoncristiani, B. Canaud,H.KÖhler, T. Petitclerc, and P. Zucchelli, "Dialysis dose and frequency," Nephrology Dialysis Transplantation, vol. 20, no. 2, pp. 285-296, 2005.
4. M. J. Evans and M. H. Kaufman, "Establishment in culture of pluripotential cells from mouse embryos," Nature, vol. 292, no. 5819, pp. 154-156, 1981.
5. K. Takahashi and S. Yamanaka, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors," Cell, vol. 126, no. 4, pp. 663-676, 2006.
6. K. Takahashi, K. Tanabe, M. Ohnuki et al., "Induction of pluripotent stem cells from adult human fibroblasts by defined factors," Cell, vol. 131, no. 5, pp. 861-872, 2007.
7. J. R. Spence, C. N. Mayhew, S. A. Rankin et al., "Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro," Nature, vol. 470, no. 7332, pp. 105-110, 2011.
8. D. C. Hay, D. Zhao, J. Fletcher et al., "Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo," Stem Cells, vol. 26, no. 4, pp. 894-902, 2008.
9. H. Basma, A. Soto-Gutiérrez, G. R. Yannam et al., "Differentiation and transplantation of human embryonic stemcell-derived hepatocytes," Gastroenterology, vol. 136, no. 3, pp. 990.e4-999.e4, 2009.
10. S. K. Dhara and S. L. Stice, "Neural differentiation of human embryonic stem cells," Journal of Cellular Biochemistry, vol. 105, no. 3, pp. 633-640, 2008.
11. S. M. Chambers, C. A. Fasano, E. P. Papapetrou,M. Tomishima, M. Sadelain, and L. Studer, "Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling," Nature Biotechnology, vol. 27, no. 3, pp. 275-280, 2009.
12. M. H. Ledran, A. Krassowska, L. Armstrong et al., "Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches," Cell Stem Cell, vol. 3, no. 1, pp. 85-98, 2008.
13. K. A. D'Amour, A. G. Bang, S. Eliazer et al., "Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells," Nature Biotechnology, vol. 24, no. 11, pp. 1392-1401, 2006.
14. D. Zhang,W. Jiang, M. Liu et al., "Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulinproducing cells," Cell Research, vol. 19, no. 4, pp. 429-438, 2009.
15. T. Takahashi, B. Lord, P. C. Schulze et al., "Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes," Circulation, vol. 107, no. 14, pp. 1912-1916, 2003.
16. A. Q. Lam, B. S. Freedman, R. Morizane, P. H. Lerou, M. T. Valerius, and J.V. Bonventre, "Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers," Journal of the American Society of Nephrology, vol. 25, no. 6, pp. 1211-1225, 2014.
17. P. Gadue, T. L. Huber, P. J. Paddison, and G. M. Keller, "Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 45, pp. 16806-16811, 2006.
18. S.-I. Mae, A. Shono, F. Shiota et al., "Monitoring and robust induction of nephrogenic intermediate mesodermfromhuman pluripotent stem cells," Nature Communications, vol. 4, article 1367, 2013.
19. Y. Xia, E. Nivet, I. Sancho-Martinez et al., "Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells," Nature Cell Biology, vol. 15, no. 12, pp. 1507-1515, 2013.
20. M. Takasato, P. X. Er, M. Becroft et al., "Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney," Nature Cell Biology, vol. 16, no. 1, pp. 118-126, 2014.
21. A. Taguchi, Y. Kaku, T. Ohmori et al., "Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells," Cell Stem Cell, vol. 14, no. 1, pp. 53-67, 2014.
22. J. Blake and N. D. Rosenblum, "Renal branching morphogenesis: morphogenetic and signalingmechanisms," Seminars in Cell & Developmental Biology, vol. 36, pp. 2-12, 2014.
23. T. Araoka, S. I. Mae, Y. Kurose et al., "Efficient and rapid induction of human iPSCs/ESCs into nephrogenic intermediate mesoderm using small molecule-based differentiation methods," PLoS ONE, vol. 9, no. 1,Article ID e84881, 2014.
24. B. G. Herrmann, S. Labeit, A. Poustka, T. R. King, and H. Lehrach, "Cloning of the T gene required in mesoderm formation in the mouse," Nature, vol. 343, no. 6259, pp. 617-622, 1990.
25. V. Wilson, I. Olivera-Martinez, K. G. Storey et al., "Stem cells, signals and vertebrate body axis extension," Development, vol. 136, no. 10, pp. 1591-1604, 2009.
26. P. W. Burridge, G. Keller, J. D. Gold, and J. C.Wu, "Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming," Cell Stem Cell, vol. 10, no. 1, pp. 16-28, 2012.
27. T. P. Yamaguchi, S. Takada, Y. Yoshikawa, N. Wu, and A. P. McMahon, "T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification," Genes and Development, vol. 13, no. 24, pp. 3185-3190, 1999.
28. J.Chen, R. Lansford,V. Stewart, F. Young, and F. W. Alt, "RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development," Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 10, pp. 4528-4532, 1993.
29. S. M. Müller, G. Terszowski, C. Blum et al., "Gene targeting of VEGF-A in thymus epithelium disrupts thymus blood vessel architecture," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 30, pp. 10587-10592, 2005.
30. D. Fraidenraich, E. Stillwell, E. Romero et al., "Rescue of cardiac defects in Id knockout embryos by injection of embyonic stem cells," Science, vol. 306, no. 5694, pp. 247-252, 2004.
31. H. Ueno and I. L. Weissman, "Clonal analysis of mouse development reveals a polyclonal origin for yolk sac blood islands," Developmental Cell, vol. 11, no. 4, pp. 519-533, 2006.
32. H. Ueno, B. B. Turnbull, and I. L. Weissman, "Two-step oligoclonal development of male germ cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 1, pp. 175-180, 2009.
33. S. Espejel, G. R. Roll, K. J. McLaughlin et al., "Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabi lities needed for liver regeneration in mice," Journal of Clinical Investigation, vol. 120, no. 9, pp. 3120-3126, 2010.
34. T. Kobayashi, T. Yamaguchi, S. Hamanaka et al., "Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells," Cell, vol. 142, no. 5, pp. 787-799, 2010.
35. H. Matsunari, H. Nagashima, M. Watanabe et al., "Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs," Proceedings of the National Academy of Sciences of theUnited States of America, vol. 110, no. 12, pp. 4557-4562, 2013.
36. J.-I. Usui, T. Kobayashi, T. Yamaguchi, A. S. Knisely, R. Nishinakamura, and H. Nakauchi, "Generation of kidney from pluripotent stem cells via blastocyst complementation," The American Journal of Pathology, vol. 180, no. 6, pp. 2417-2426, 2012.
37. S. Aggarwal, A. Moggio, and B. Bussolati, "Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives," Stem Cells Translational Medicine, vol. 2, no. 12, pp. 1011-1019, 2013.
38. H.A.Hartman,H.L.Lai, andL. T. Patterson, "Cessationof renal morphogenesis in mice," Developmental Biology, vol. 310, no. 2, pp. 379-387, 2007.
39. J. A. Oliver, O.Maarouf, F.H. Cheema, T. P.Martens, and Q. Al-Awqati, "The renal papilla is a niche for adult kidney stem cells," The Journal of Clinical Investigation, vol. 114, no. 6, pp. 795-804, 2004.
40. A. Maeshima, S. Yamashita, and Y. Nojima, "Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney," Journal of the American Society of Nephrology, vol. 14, no. 12, pp. 3138-3146, 2003.
41. C. Sagrinati, G. S. Netti, B.Mazzinghi et al., "Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys," Journal of theAmerican Society of Nephrology, vol. 17, no. 9, pp. 2443-2456, 2006.
42. S. Kitamura, Y. Yamasaki, M. Kinomura et al., "Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney,"TheFASEB Journal, vol. 19, no. 13, pp. 1789-1797, 2005.
43. D. Lindgren, A.-K. BostrÖm, K. Nilsson et al., "Isolation and characterization of progenitor-like cells from human renal proximal tubules," The American Journal of Pathology, vol. 178, no. 2, pp. 828-837, 2011.
44. S. Kitamura, H. Sakurai, and H. Makino, "Single adult kidney stem/progenitor cells reconstitute three-dimensional nephron structures in vitro," Stem Cells, 2014.
45. A. A. Simerman, D. A. Dumesic, and G. D. Chazenbalk, "Pluripotent muse cells derived from human adipose tissue: A new perspective on regenerative medicine and cell therapy," Clinical and Translational Medicine, vol. 3, article 12, 2014.
46. Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt et al., "Pluripotency ofmesenchymal stemcells derived from adultmarrow," Nature, vol. 418, no. 6893, pp. 41-49, 2002.
47. I. Dimomeletis, E. Deindl, M. Zaruba et al., "Assessment of humanMAPCs for stemcell transplantation and cardiac regeneration aftermyocardial infarction in SCID mice," Experimental Hematology, vol. 38, no. 11, pp. 1105-1114, 2010.
48. J. J. Song and H. C. Ott, "Organ engineering based on decellularized matrix scaffolds," Trends in Molecular Medicine, vol. 17, no. 8, pp. 424-432, 2011.
49. J. Oliver, "Correlations of structure and function and mechanisms of recovery in acute tubular necrosis," The American Journal of Medicine, vol. 15, no. 4, pp. 535-557, 1953.
50. F. E. Cuppage and A. Tate, "Repair of the nephron following injury with mercuric chloride.,"TheAmerican Journal of Pathology, vol. 51, no. 3, pp. 405-429, 1967.
51. B. H. Haagsma and A. W. Pound, "Mercuric chloride-induced tubulonecrosis in the rat kidney: The recovery phase," British Journal of Experimental Pathology, vol. 61, no. 3, pp. 229-241, 1980.
52. M. Salvatori, A. Peloso, R. Katari, and G. Orlando, "Regeneration and bioengineering of the kidney: current status and future challenges," Current Urology Reports, vol. 15, no. 1, article 379, 2014.
53. B. Lelongt and P. Ronco, "Role of extracellular matrix in kidney development and repair," Pediatric Nephrology, vol. 18, no. 8, pp. 731-742, 2003.
54. G. Orlando, P. Baptista, M. Birchall et al., "Regenerative medicine as applied to solid organ transplantation: current status and future challenges," Transplant International, vol. 24, no. 3, pp. 223-232, 2011.
55. H. C. Ott, T. S. Matthiesen, S.-K. Goh et al., "Perfusiondecellularized matrix: using nature's platform to engineer a bioartificial heart," Nature Medicine, vol. 14, no. 2, pp. 213-221, 2008.
56. P. M. Baptista, M. M. Siddiqui, G. Lozier, S. R. Rodriguez, A. Atala, and S. Soker, "The use of whole organ decellularization for the generation of a vascularized liver organoid," Hepatology, vol. 53, no. 2, pp. 604-617, 2011.
57. J. J. Song, S. S. Kim, Z. Liu et al., "Enhanced in vivo function of bioartificial lungs in rats," The Annals of Thoracic Surgery, vol. 92, no. 3, pp. 998-1006, 2011.
58. P. M. Crapo, C. J.Medberry, J. E. Reing et al., "Biologic scaffolds composed of central nervous system extracellular matrix," Biomaterials, vol. 33, no. 13, pp. 3539-3547, 2012.
59. T. Martinello, I. Bronzini, A. Volpin et al., "Successful recellularization of human tendon scaffolds using adipose-derived mesenchymal stem cells and collagen gel," Journal of Tissue Engineering and Regenerative Medicine, vol. 8, no. 8, pp. 612-619, 2014.
60. J. L. Honge, J. Funder, E. Hansen, P. M. Dohmen, W. Konertz, and J.M. Hasenkam, "Recellularization of aortic valves in pigs," European Journal of Cardio-Thoracic Surgery, vol. 39, no. 6, pp. 829-834, 2011.
61. Y. Loai, H. Yeger, C. Coz et al., "Bladder tissue engineering: tissue regeneration and neovascularization of HA-VEGFincorporated bladder acellular constructs in mouse and porcine animal models," Journal of Biomedical MaterialsResearch-Part A, vol. 94, no. 4, pp. 1205-1215, 2010.
62. M. S. Wicha, G. Lowrie, E. Kohn, P. Bagavandoss, and T. Mahn, "Extracellular matrix promotes mammary epithelial growth and differentiation in vitro," Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 10, pp. 3213-3217, 1982.
63. E. A. Ross, M. J. Williams, T. Hamazaki et al., "Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds," Journal of theAmerican Society of Nephrology, vol. 20, no. 11, pp. 2338-2347, 2009.
64. K. H. Nakayama, C. A. Batchelder, C. I. Lee, and A. F. Tarantal, "Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering," Tissue Engineering-Part A, vol. 16, no. 7, pp. 2207-2216, 2010.
65. D. C. Sullivan, S.-H. Mirmalek-Sani, D. B. Deegan et al., "Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system," Biomaterials, vol. 33, no. 31, pp. 7756-7764, 2012.
66. J. J. Song, J. P. Guyette, S. E. Gilpin, G. Gonzalez, J. P. Vacanti, and H. C. Ott, "Regeneration and experimental orthotopic transplantation of a bioengineered kidney," Nature Medicine, vol. 19, no. 5, pp. 646-651, 2013.
67. S. M. Mackay, A. J. Funke, D. A. Buffington, and H. David Humes, "Tissue engineering of a bioartificial renal tubule," ASAIO Journal, vol. 44, no. 3, pp. 179-183, 1998.
68. H. D. Humes, S. M. MacKay, A. J. Funke, and D. A. Buffington, "Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics," Kidney International, vol. 55, no. 6, pp. 2502-2514, 1999.
69. J. H. Song and H. D. Humes, "The bioartificial kidney in the treatment of acute kidney injury," Current Drug Targets, vol. 10, no. 12, pp. 1227-1234, 2009.
70. H. D. Humes, J. C. Krauss, D. A. Cieslinski, and A. J. Funke, "Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus," The American Journal of Physiology-Renal Fluid and Electrolyte Physiology, vol. 271, no. 1, pp. F42-F49, 1996.
71. H.D.Humes,D.A. Buffington, S. M. MacKay, A. J. Funke, and W. F.Weitzel, "Replacement of renal function in uremic animals with a tissue-engineered kidney," Nature Biotechnology, vol. 17, no. 5, pp. 451-455, 1999.
72. H. D. Humes,W. F.Weitzel, R. H. Bartlett et al., "Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure," Kidney International, vol. 66, no. 4, pp. 1578-1588, 2004.
73. J. Tumlin, R. Wali, W. Williams et al., "Efficacy and safety of renal tubule cell therapy for acute renal failure," Journal of the American Society of Nephrology, vol. 19, no. 5, pp. 1034-1040, 2008.
74. H. D.Humes, J. T. Sobota, F. Ding, and J. H. Song, "A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure," Blood Purification, vol. 29, no. 2, pp. 183-190, 2010.
75. S. A. Rogers, J. A. Lowell, N. A. Hammerman, and M. R. Hammerman, "Transplantation of developing metanephroi into adult rats," Kidney International, vol. 54, no. 1, pp. 27-37, 1998.
76. M. R. Hammerman, "Renal Organogenesis from Transplanted Metanephric Primordia," Journal of the American Society of Nephrology, vol. 15, no. 5, pp. 1126-1132, 2004.
77. K. Matsumoto, T. Yokoo, S. Yokote, Y. Utsunomiya, T. Ohashi, and T. Hosoya, "Functional development of a transplanted embryonic kidney: effect of transplantation site," Journal of Nephrology, vol. 25, no. 1, pp. 50-55, 2012.
78. S. Yokote, T. Yokoo, K. Matsumoto, Y. Utsunomiya, T. Kawamura, and T. Hosoya, "The effect of metanephros transplantation on blood pressure in anephric rats with induced acute hypotension," Nephrology Dialysis Transplantation, vol. 27, no. 9, pp. 3449-3455, 2012.
79. S. Yokote, T. Yokoo, K. Matsumoto et al., "Metanephros transplantation inhibits the progression of vascular calcification in rats with adenine-induced renal failure," Nephron-Experimental Nephrology, vol. 120, no. 1, pp. e32-e40, 2012.
80. S. A. Rogers,M. Talcott, and M. R.Hammerman, "Transplantation of pigmetanephroi," American Society for Artificial Internal Organs, vol. 49, no. 1, pp. 48-52, 2003.
81. B. Dekel, T. Burakova, F. D. Arditti et al., "Human and porcine early kidney precursors as a new source for transplantation," Nature Medicine, vol. 9, no. 1, pp. 53-60, 2003.
82. S.-I. Takeda, S. A. Rogers, andM. R.Hammerman, "Differential origin for endothelial and mesangial cells after transplantation of pig fetal renal primordia into rats," Transplant Immunology, vol. 15, no. 3, pp. 211-215, 2006.
83. S. A. Rogers and M. R. Hammerman, "Prolongation of life in anephric rats following de novo renal organogenesis," Organogenesis, vol. 1, no. 1, pp. 22-25, 2004.
84. K.Matsumoto, T. Yokoo,H.Matsunari et al., "Xenotransplanted embryonic kidney provides a niche for endogenous mesenchymal stem cell differentiation into erythropoietin-producing tissue," Stem Cells, vol. 30, no. 6, pp. 1228-1235, 2012.
85. S. Yokote and T. Yokoo, "Organogenesis for kidney regeneration," Current Opinion in Organ Transplantation, vol. 18, no. 2, pp. 186-190, 2013.
86. C. Xinaris and T. Yokoo, "Reforming the kidney starting froma single-cell suspension," Nephron: Experimental Nephrology, vol. 126, no. 2, pp. 107-112, 2014.
87. T. Yokoo, T. Ohashi, S. S. Jin et al., "Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 9, pp. 3296-3300, 2005.
88. T. Yokoo, A. Fukui, T. Ohashi et al., "Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo," Journal of the American Society of Nephrology, vol. 17, no. 4, pp. 1026-1034, 2006.
89. A. Fukui, T. Yokoo, K. Matsumoto, T. Kawamura, T. Hosoya, and M. Okabe, "Integration of human mesenchymal stem cells into the Wolffian duct in chicken embryos," Biochemical and Biophysical Research Communications, vol. 385, no. 3, pp. 330-335, 2009.
90. L. Saxén and H. Sariola, "Early organogenesis of the kidney," Pediatric Nephrology, vol. 1, no. 3, pp. 385-392, 1987.
91. J. A. Davies and C. E. Fisher, "Genes and proteins in renal development," Experimental Nephrology, vol. 10, no. 2, pp. 102-113, 2002.
92. Y.Gheisari, T. Yokoo, K. Matsumoto et al., "Athermoreversible polymer mediates controlled release of glial cell line-derived neurotrophic factor to enhance kidney regeneration," Artificial Organs, vol. 34, no. 8, pp. 642-647, 2010.
93. T. Yokoo, A. Fukui, K. Matsumoto et al., "Generation of a transplantable erythropoietin-producer derived from human mesenchymal stem cells," Transplantation, vol. 85, no. 11, pp. 1654-1658, 2008.
94. S. Yamanaka, S. Yokote, A. Yamada et al., "Adipose tissuederived mesenchymal stem cells in long-term dialysis patients display downregulation of PCAF expression and poor angiogenesis activation," PLoS ONE, vol. 9, no. 7, Article ID e102311, 2014.